Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital, University of Toronto, ON, Canada.
AJR Am J Roentgenol. 2011 Mar;196(3):562-8. doi: 10.2214/AJR.10.4729.
The purpose of this study is to compare intraoperative ultrasound and preoperative contrast-enhanced MRI or 64-MDCT for the depiction of malignant lesions and for prediction of hepatic segments positive and negative for malignancy in patients undergoing partial hepatic resection.
In this retrospective study, 292 patients undergoing hepatic resection for metastatic colorectal cancer (n = 168), hepatocellular carcinoma (n = 70), or other hepatic malignancies (n = 54) were included. The sensitivity and negative predictive value of intraoperative ultrasound and preoperative cross-sectional imaging were calculated. The mean (± SD) time intervals to surgery were 37.6 ± 26 days for 64-MDCT and 48.1 ± 34 days for MRI. Surgical histopathologic examination was the reference standard. Changes in surgical management were recorded. Logistic regression models were used to estimate and compare proportions.
For all 561 malignant lesions, the sensitivity of intraoperative ultrasound was 95.1%, compared with 96.8% for 64-MDCT (p = 0.025) and 94.4% for MRI (p = 0.960); 64-MDCT was also more sensitive than intraoperative ultrasound in identifying positive liver segments (p = 0.013). After controlling for patient group and time interval between imaging and surgery, the negative predictive value of 64-MDCT and MRI was higher than that of intraoperative ultrasound (p < 0.001 and p = 0.040, respectively). In only eight cases (2.7%) was surgical management changed after intraoperative ultrasound.
For patients undergoing partial liver resection for hepatic malignancies, 64-MDCT and MRI have an equivalent or higher sensitivity in identifying hepatic segments with malignancy, and both 64-MDCT and MRI appear to have a higher predictive value for identifying disease-free segments than does intraoperative ultrasound.
本研究旨在比较术中超声与术前对比增强 MRI 或 64 层 MDCT 对恶性病变的显示,并预测行部分肝切除术的患者中恶性病变阳性和阴性肝段。
在这项回顾性研究中,纳入了 292 例因转移性结直肠癌(n = 168)、肝细胞癌(n = 70)或其他肝脏恶性肿瘤(n = 54)而行肝切除术的患者。计算了术中超声和术前横断面成像的敏感性和阴性预测值。64 层 MDCT 和 MRI 的平均(±SD)手术间隔时间分别为 37.6 ± 26 天和 48.1 ± 34 天。手术病理检查为参考标准。记录了手术管理的变化。使用逻辑回归模型来估计和比较比例。
对于所有 561 个恶性病变,术中超声的敏感性为 95.1%,而 64 层 MDCT 为 96.8%(p = 0.025),MRI 为 94.4%(p = 0.960);64 层 MDCT 也比术中超声更能识别阳性肝段(p = 0.013)。在控制患者组和成像与手术之间的时间间隔后,64 层 MDCT 和 MRI 的阴性预测值均高于术中超声(p < 0.001 和 p = 0.040)。仅在 8 例(2.7%)患者中,术中超声后手术管理发生了变化。
对于行部分肝切除术治疗肝脏恶性肿瘤的患者,64 层 MDCT 和 MRI 在识别恶性肝段方面具有同等或更高的敏感性,并且 64 层 MDCT 和 MRI 似乎比术中超声具有更高的预测无病肝段的价值。